Two Sigma Investments’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,700
| Closed | -$833K | – | 3344 |
|
|
2024
Q1 | $833K | Hold |
19,700
| – | – | ﹤0.01% | 2004 |
|
|
2023
Q4 | $835K | Sell |
19,700
-4,300
| -18% | -$182K | ﹤0.01% | 2105 |
|
|
2023
Q3 | $524K | Sell |
24,000
-8,300
| -26% | -$181K | ﹤0.01% | 2182 |
|
|
2023
Q2 | $1.03M | Buy |
32,300
+18,600
| +136% | +$591K | ﹤0.01% | 1862 |
|
|
2023
Q1 | $334K | Buy |
13,700
+5,700
| +71% | +$139K | ﹤0.01% | 2301 |
|
|
2022
Q4 | $252K | Buy |
+8,000
| New | +$252K | ﹤0.01% | 2249 |
|